Information for StakeholdersFive major shareholders of Speedel informed the Board of Directors on 9 July 2008 that they agreed to sell all their registered shares to Novartis. After acquiring these shares Novartis launched a mandatory public tender offer to acquire the remaining shares and intends to integrate Speedel into Novartis by the end of the year. Following completion of the mandatory public tender offer, Novartis announced on 25 September 2008 that it holds 99.8% of the current outstanding public shares in Speedel Holding Ltd. A “squeeze out” procedure is underway to cancel remaining shares under the same terms of the public tender offer (CHF 130 per share). This procedure, which is governed by Swiss law, is expected to close in early 2009. The shares of Speedel Holding Ltd. will be delisted from the Swiss Stock Exchange upon completion of the cancellation procedure. For information on Novartis see www.novartis.com. Here you can find additional information for Speedel's stakeholders.
|
